What rehab taught me about making bad investments
(Editor’s note: Jeff Bussgang is a General Partner at Flybridge Capital Partners. This column originally appeared on his blog Seeing Both Sides.)
For as long as I can remember, I have been an enthusiastic participant in sports. To be clear, I’m not a great athlete (in fact, I’m… Continue Reading
Predictive Biosciences raises $21.8M for cancer diagnostic tech
Predictive Biosciences, a company that hopes to improve the way cancer is diagnosed and monitored, announced that it brought in $21.8 million in second-round financing led by New Enterprise Associates and including contributions from Kaiser Permanente Ventures, Flybridge Venture Capital and Highland Capital Partners. This… Continue Reading